APA (7th ed.) Citation

D, Y., AM, D., C, Y., C, I., WF, S., KS, A., . . . DA, B. (2020). Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial. JAMA oncology, 6(9), 1355. https://doi.org/10.1001/jamaoncol.2020.2535

Chicago Style (17th ed.) Citation

D, Yee, et al. "Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial." JAMA Oncology 6, no. 9 (2020): 1355. https://doi.org/10.1001/jamaoncol.2020.2535.

MLA (9th ed.) Citation

D, Yee, et al. "Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial." JAMA Oncology, vol. 6, no. 9, 2020, p. 1355, https://doi.org/10.1001/jamaoncol.2020.2535.